I-MAB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.76 USD | -0.28% |
|
-2.22% | -7.37% |
| 04-18 | Verastem Names John Hayslip as Chief Medical Officer | MT |
| 04-15 | I-Mab Announces Chief Medical Officer Changes | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 1.810 | 2.370 | 3.180 |
| Spread/Res. | -2.76% | -25.74% | -44.65% |
| Spread/Supp. | +1.15% | +26.62% | +46.67% |
| Support | 1.740 | 1.390 | 1.200 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- IMAB Stock
- Charts I-Mab
